Matteo Bassetti to Adult
This is a "connection" page, showing publications Matteo Bassetti has written about Adult.
Connection Strength
0.137
-
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis. 2021 Apr 15; 21(1):353.
Score: 0.016
-
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. PLoS One. 2020; 15(8):e0237831.
Score: 0.015
-
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection. Eur J Clin Invest. 2020 Oct; 50(10):e13358.
Score: 0.015
-
Serological and T Cell Responses After Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis. Viral Immunol. 2019 04; 32(3):151-157.
Score: 0.013
-
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems. Eur J Clin Microbiol Infect Dis. 2018 Nov; 37(11):2083-2089.
Score: 0.013
-
HSV-1 cutaneous infection in a patient with Hodgkin's lymphoma treated with brentuximab vedotin. J Chemother. 2013 Dec; 25(6):381-2.
Score: 0.009
-
Incidence, timing and site of infections among pancreas transplant recipients. J Hosp Infect. 2004 Mar; 56(3):184-90.
Score: 0.005
-
Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol. 2021 09; 93(9):5608-5613.
Score: 0.004
-
A modular framework for the development of targeted Covid-19 blood transcript profiling panels. J Transl Med. 2020 07 31; 18(1):291.
Score: 0.004
-
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey. J Crit Care. 2020 10; 59:70-75.
Score: 0.004
-
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study. J Antimicrob Chemother. 2019 12 01; 74(12):3588-3595.
Score: 0.004
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
Score: 0.003
-
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018 09 11; 320(10):984-994.
Score: 0.003
-
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp. Eur J Clin Pharmacol. 2018 Nov; 74(11):1449-1459.
Score: 0.003
-
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts. J Chemother. 2018 May; 30(3):157-171.
Score: 0.003
-
Isavuconazole shortens the QTc interval. Mycoses. 2018 Apr; 61(4):256-260.
Score: 0.003
-
Epidemiological and clinical features of imported malaria at the three main hospitals of the Friuli-Venezia Giulia Region, Italy. Infect Dis Health. 2018 03; 23(1):17-22.
Score: 0.003
-
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2017 10; 61(10).
Score: 0.003
-
Individualizing duration of antibiotic therapy in community-acquired pneumonia. Pulm Pharmacol Ther. 2017 08; 45:191-201.
Score: 0.003
-
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies. Mycoses. 2017 Oct; 60(10):663-667.
Score: 0.003
-
Pulmonary nodules in African migrants caused by chronic schistosomiasis. Lancet Infect Dis. 2017 05; 17(5):e159-e165.
Score: 0.003
-
Epidemiology of Strongyloides stercoralis in northern Italy: results of a multicentre case-control study, February 2013 to July 2014. Euro Surveill. 2016 Aug 04; 21(31).
Score: 0.003
-
Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence study. J Prev Med Hyg. 2010 Jun; 51(2):80-6.
Score: 0.002
-
Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort. Infection. 2008 Aug; 36(4):358-61.
Score: 0.002